(19)
(11) EP 3 784 217 A1

(12)

(43) Date of publication:
03.03.2021 Bulletin 2021/09

(21) Application number: 18729320.4

(22) Date of filing: 26.04.2018
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
 A61K 31/222(2006.01)
(86) International application number:
PCT/EP2018/000223
(87) International publication number:
WO 2019/206391 (31.10.2019 Gazette 2019/44)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicants:
  • Rontis Hellas S.A.
    151 25 Marousi Athens (GR)
  • Pharos Ltd.
    144 52 Metamorfosiattikis (GR)

(72) Inventors:
  • GRYPIOTI, Agni
    151 25 Marousi, Athens (GR)
  • TSITSAS, Panagiotis
    151 25 Marousi, Athens (GR)

   


(54) EXTENDED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING FESOTERODINE AND PROCESS FOR THE PREPARATION THEREOF